openPR Logo
Press release

Venous Thromboembolism Treatment Market Size is anticipated to grow with a significant CAGR by 2034, estimates DelveInsight | Pfizer, Bristol-Myers Squibb, Bayer, Janssen LLC, Johnson & Johnson Pharma, Cristália Produtos Químicos Farmacêuticos Ltda.

02-24-2025 02:46 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Venous Thromboembolism Market

Venous Thromboembolism Market

DelveInsight's "Venous Thromboembolism Market Insights, Epidemiology, and Market Forecast 2034" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Venous Thromboembolism Market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

Key Takeaways from the Venous Thromboembolism Market Research Report
• As per the study by Ota et al., (2015), titled "Incidence, Characteristics and Management of Venous Thromboembolism in Japan During 2011,", nearly 16,096 and 24,538 individuals in Japan were diagnosed with new PE and DVT, respectively, during 2011, which represented overall annual incidences of 12.6 and 19.2 per 100,000, respectively.
• A multinational report of European Union countries estimated that the total number of symptomatic, nonfatal VTE events per annum was more than 465,000 cases of DVT and more than 295,000 cases of PE.
• The Venous Thromboembolism Companies working in the market include Pfizer, Bristol-Myers Squibb, Bayer, Janssen LLC, Johnson & Johnson Pharma, Cristália Produtos Químicos Farmacêuticos Ltda., LEO Pharma, Sanofi, Daiichi Sankyo Inc., Astellas Pharma Inc., Boehringer Ingelheim, Regeneron Pharmaceuticals, and others.
• Promising Venous Thromboembolism Pipeline Therapies in the various stages of development include apixaban, warfarin, Rivaroxaban (Xarelto, BAY59-7939), Enoxaparin, Enoxaparin, and others.

Request for Sample Report @ Venous Thromboembolism Market Size Report- https://www.delveinsight.com/sample-request/venous-thromboembolism-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Venous Thromboembolism Overview
Venous Thromboembolism (VTE) is a disorder that includes Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) . A deep vein thrombosis (DVT) occurs when a blood clot forms in a deep vein, usually in the lower leg, thigh, or pelvis. A deep vein thrombosis may occur if the flow of blood slows down in the body's deep veins. A pulmonary embolism (PE) occurs when a clot breaks loose and travels through the bloodstream to the lungs.

Venous Thromboembolism Market
The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Venous Thromboembolism market size by analyzing the impact of current and emerging therapies in the market. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies.
The report details the Venous Thromboembolism market trend for each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, mechanism of action (MoA), competition with other therapies, brand value, and their impact on the market.

Venous Thromboembolism Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Venous Thromboembolism Epidemiology Segmentation
• Total Incident Cases
• Total Diagnosed Cases
• Type-specific Cases
• Total Age-specific Cases
• Occurrence-specific Cases
• Total Prophylactic/Preventive Setting Cases
• Total Potential (Mortality and Recurrent adjusted) Cases
• Total Treated Cases of VTE for Treatment and Prophylactic Settings

Download the report to understand which factors are driving Venous Thromboembolism epidemiology trends @ Venous Thromboembolism Epidemiological Insights- https://www.delveinsight.com/sample-request/venous-thromboembolism-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Venous Thromboembolism Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Venous Thromboembolism market or expected to get launched during the study period. The analysis covers Venous Thromboembolism market uptake by drugs, patient uptake by therapies, and sales of each drug. Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

Venous Thromboembolism Therapeutics Analysis
The Venous Thromboembolism market dynamics are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, rising awareness of the diseases, and incremental healthcare spending worldwide.

Key Companies in the Venous Thromboembolism Market include:
• Ionis Pharmaceuticals
• Bristol-Myers Squibb
• Janssen Pharmaceuticals
• Quercis Pharmaceuticals
• Ono Pharmaceutical
• Verseon Corporation
• Bayer Pharmaceuticals

Venous Thromboembolism Therapies covered in the report include:
• ONO-7684
• Milvexian
• Isoquercetin
• VE-1902
• IONIS-FXI-LRx
• Osocimab (BAY 1213790)

Get More Detailed Insights into the Emerging Therapies & Key Companies - Venous Thromboembolism Clinical Trials Assessment- https://www.delveinsight.com/sample-request/venous-thromboembolism-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Key Insights
2. Executive Summary
3. Venous Thromboembolism Competitive Intelligence Analysis
4. Venous Thromboembolism Market Overview at a Glance
5. Venous Thromboembolism Disease Background and Overview
6. Venous Thromboembolism Patient Journey
7. Venous Thromboembolism Epidemiology and Patient Population
8. Venous Thromboembolism Treatment Algorithm, Current Treatment, and Medical Practices
9. Venous Thromboembolism Unmet Needs
10. Key Endpoints of Venous Thromboembolism Treatment
11. Venous Thromboembolism Marketed Products
12. Venous Thromboembolism Emerging Therapies
13. Venous Thromboembolism Seven Major Market Analysis
14. Attribute Analysis
15. Venous Thromboembolism Market Outlook (7 major markets)
16. Venous Thromboembolism Access and Reimbursement Overview
17. KOL Views on the Venous Thromboembolism Market.
18. Venous Thromboembolism Market Drivers
19. Venous Thromboembolism Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer

List of the Top Selling Market Research Reports in 2025
intraocular lens market- https://www.delveinsight.com/blog/top-companies-in-the-intraocular-lens-market
vulvar cancer market- https://www.delveinsight.com/report-store/vulvar-cancer-pipeline-insight
healthcare competitive benchmarking- https://www.delveinsight.com/consulting/competitive-benchmarking-services
novel drug delivery devices market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
microscopy device market- https://www.delveinsight.com/report-store/microscopy-device-market
phototherapies for psoriasis market- https://www.delveinsight.com/report-store/chronic-plaque-psoriasis-market
urea cycle disorders market- https://www.delveinsight.com/blog/urea-cycle-disorder-market
antibody drug conjugate market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
surgical mask & respirator market- https://www.delveinsight.com/report-store/surgical-mask-respirator-market
sepsis market- https://www.delveinsight.com/report-store/sepsis-market-insight
lactose intolerance market- https://www.delveinsight.com/report-store/lactose-intolerance-market
bone growth stimulator market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
lymphoedema market- https://www.delveinsight.com/report-store/lymphoedema-market
cart pipeline- https://www.delveinsight.com/report-store/cart-cell-therapy-competitive-landscape
dyspepsia market- https://www.delveinsight.com/report-store/functional-dyspepsia-pipeline-insight
total knee arthroplasty market- https://www.delveinsight.com/report-store/knee-reconstruction-devices-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Venous Thromboembolism Treatment Market Size is anticipated to grow with a significant CAGR by 2034, estimates DelveInsight | Pfizer, Bristol-Myers Squibb, Bayer, Janssen LLC, Johnson & Johnson Pharma, Cristália Produtos Químicos Farmacêuticos Ltda. here

News-ID: 3883726 • Views:

More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay ahead
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market

All 5 Releases


More Releases for Venous

States Venous Stents Market Projected to Witness Expansion with Rising Incidence …
States Venous Stents Market Overview The States Venous Stents Market is expected to grow from USD 1.3 billion in 2025 to USD 2.4 billion by 2032, registering a CAGR of 8.9%. Coherent Market Insights is pleased to release its latest States Venous Stents Market research report, offering an in-depth analysis of the U.S. States Venous Stents Market Landscape from 2025 to 2032. This report delivers reliable projections across national and regional levels,
Venous Stent Market Grows with Rising Cases of Chronic Venous Disorders | Boston …
Venous Stent Market Overview The venous stent market is anticipated to grow from USD 0.6 billion in 2025 to USD 1.3 billion by 2032, exhibiting a CAGR of 10.3% during the forecast period. Coherent Market Insights is proud to announce the release of its latest market research report, providing a comprehensive analysis of the Venous Stent Market Landscape from 2025 to 2032. This report delivers precise forecasts across global, regional, and country
Major Force in the Venous Thromboembolism Market 2025: Impact Of Healthcare Infr …
How Will the Venous Thromboembolism Market Grow, and What Is the Projected Market Size? Over the past few years, the venous thromboembolism market has experienced a steady increase in its size. It's projected to expand from $2.44 billion in 2024 to $2.55 billion in 2025, rising at a compound annual growth rate (CAGR) of 4.4%. The growth during the historic period can be credited to an increasing elderly population, progress in
Venous Catheter Market Size 2024 to 2031.
Market Overview and Report Coverage A venous catheter is a small, flexible tube inserted into a vein for medical purposes such as accessing the bloodstream for medications, fluids, or blood sampling. The venous catheter market is expected to witness significant growth in the coming years, with a projected CAGR of 6.30% during the forecasted period. The current outlook for the venous catheter market is positive, driven by factors such as
Increasing Prevalence of Venous Thromboembolism to Augment Growth of the Venous …
Venous thromboembolism (VTE) is the formation of blood clots in the bloodstream. Two main types of venous thromboembolism are pulmonary embolism and deep vein thrombosis. The formation of blood clots in a deep vein is called deep vein thrombosis, while the deep vein thrombosis formed breaks the clot and travels to the lungs, known as pulmonary embolism. Sample Copy Of Report @ https://www.coherentmarketinsights.com/insight/request-sample/188 Pulmonary embolism occurs in almost one-third of patients
Venous Thromboembolism Treatment Market Analysis by 2028
Global Venous Thromboembolism Treatment Market: Overview When a blood clot is stuck in a vein is known as venous thromboembolism (VTE), this block the flow of blood to the other parts. A person facing this situation requires immediate medical attention. According to various studies, venous thromboembolism is considered as a third leading cause for vascular diagnosis after heart attack and stroke. There are about 300,000 to 600,000 individuals facing